CMS Open Payments · Program Year 2024
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. reported $14,521,670.06 in payments to 186,436 physicians and teaching hospitals across 186,436 transactions.
- $14.5M
- Total payments
- 186,436
- Transactions
- 186,436
- Recipients
- +$667.7K
- General Payments vs PY2023
Otsuka America Pharmaceutical, Inc. reported $14,521,670.06 in payments to 186,436 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #129 of 1,925 reporting manufacturers (0.1% of all US industry payments), averaging $77.89 per recipient across 8 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
The verdict
Otsuka America Pharmaceutical, Inc. pairs top-10% payment volume with an unusually diversified payment pattern across a wide recipient base.
- #129
- of 1,925 companies
- 0.1%
- of all US industry payments
- 0.0%
- paid to its single top recipient
- 8
- payment categories
Release-over-release change
General Payments changed from PY2023 to PY2024
Otsuka America Pharmaceutical, Inc.'s CMS-reported General Payments increased by $667.7K (+4.8%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.
CMS source labels for this exact identifier: PY2022: OTSUKA AMERICA PHARMACEUTICAL, INC.PY2023: OTSUKA AMERICA PHARMACEUTICAL, INC.PY2024: Otsuka America Pharmaceutical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $13,853,960.85
- PY2024
- $14,521,670.06
How Otsuka America Pharmaceutical, Inc. ranks nationally
Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.
Otsuka America Pharmaceutical, Inc.'s total vs. every reporting company
CMS Open Payments, Program Year 2024
$14,521,670 Top 7% higher than 93% of 1,925 reporting companies
Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Open Payments · 2024
What the Data Shows for Otsuka America Pharmaceutical, Inc.
$14,521,670.06: that is what Otsuka America Pharmaceutical, Inc. reported in payments to 186,436 physicians and teaching hospitals during Program Year 2024, spread across 186,436 transactions ($77.89 per transaction, $77.89 per recipient). The company sits at rank #129 of 1,925, representing 0.1% of all industry payments reported nationwide for the year.
"Compensation for Services Other Than Consulting" leads the 8-category general-payment breakdown below at $8.0M (55.1% of the company's reported total, 3,595 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 8 types of general payments, Otsuka America Pharmaceutical, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $8.0M - 55.1% of the company's reported total.
How Otsuka America Pharmaceutical, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $8.0M | 3,595 | 55.1% |
| Food and Beverage | $4.4M | 176,914 | 30.4% |
| Travel and Lodging | $1.2M | 5,557 | 8.1% |
| Consulting Fee | $620.2K | 181 | 4.3% |
| Grant | $267.1K | 2 | 1.8% |
| Space Rental or Facility Fees | $30.2K | 18 | 0.2% |
| Charitable Contribution | $3.2K | 14 | 0.0% |
| Education | $1.1K | 155 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $913,719.66 (6.3%) of $14,521,670.06 in this company's General Payments records across 54,674 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Otsuka America Pharmaceutical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Langley Porter Psychiatric Hospital
$266,050.75 across 2 reported transactions
- 2
Rebecca Roma
$172,512.46 across 253 reported transactions
- 3
Charles Nguyen
$171,302.83 across 252 reported transactions
- 4
Leslie Citrome
$152,997.30 across 192 reported transactions
- 5
Amita Rajesh Patel
$150,856.32 across 154 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Payment Size Analysis
Average transaction size: $77.89. Average per recipient: $77.89.
Total Amount
$14,521,670.06
Avg per Transaction
$77.89
Avg per Recipient
$77.89
Payment Transparency Context
What is the Sunshine Act?
The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.
Industry Total (2024)
$13.9B
across 1,925 companies
Otsuka America Pharmaceutical, Inc. Share
0.1%
#129 by total payments
Companies with Similar Payment Volumes
Pharmaceutical companies with payment totals similar to Otsuka America Pharmaceutical, Inc.
RxSight Inc
NovApproach Spine, LLC
Swedish Orphan Biovitrum Ab
Otsuka Pharmaceutical Development & Commercialization, Inc.
Roche Diagnostics Operations, Inc.
Argenx US, Inc.
Frequently Asked Questions
How much did Otsuka America Pharmaceutical, Inc. pay to physicians and hospitals in 2024? ▾
How many physicians received payments from Otsuka America Pharmaceutical, Inc.? ▾
What types of payments did Otsuka America Pharmaceutical, Inc. make? ▾
How does Otsuka America Pharmaceutical, Inc. rank among pharmaceutical companies? ▾
What is the average payment size from Otsuka America Pharmaceutical, Inc.? ▾
Where does the payment data for Otsuka America Pharmaceutical, Inc. come from? ▾
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.